Drug search by name

Blinatumomab Intravenous and Vaccination

Result of checking the interaction of drug Blinatumomab Intravenous and disease Vaccination for safety when used together.

Check result:

Blinatumomab Intravenous <> Vaccination

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The administration of live vaccines should be avoided during therapy with blinatumomab. Vaccination with live virus vaccines is not recommended for at least 2 weeks prior to start of therapy, during treatment, and until the immune system has recovered following last cycle of blinatumomab. It is recommended to be up-to-date with all required immunizations, as recommended by current immunization guidelines, before initiating therapy.

Blinatumomab Intravenous

Generic Name: blinatumomab

Brand Name: Blincyto

Synonyms: Blinatumomab

What is Blinatumomab Intravenous?